Zulresso

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Nov. 2, 2018– Sage Therapeutics (NASDAQ: SAGE), a clinical-stage biopharmaceutical company developing novel medicines to treat life-altering central nervous system (CNS) disorders, today announced that the U.S. Food […]

» Read more
1 2 3 4 5 11